| Primary |
| Rheumatoid Arthritis |
22.1% |
| Osteoarthritis |
16.1% |
| Hypertension |
10.6% |
| Back Pain |
8.3% |
| Osteoporosis |
4.7% |
| Arthralgia |
4.2% |
| Insomnia |
4.2% |
| Gastritis |
4.1% |
| Pain |
3.4% |
| Constipation |
2.7% |
| Prophylaxis |
2.6% |
| Atrial Fibrillation |
2.5% |
| Diabetes Mellitus |
2.5% |
| Spinal Osteoarthritis |
2.2% |
| Musculoskeletal Pain |
2.1% |
| Gastritis Prophylaxis |
1.9% |
| Analgesic Therapy |
1.5% |
| Reflux Oesophagitis |
1.5% |
| Angina Pectoris |
1.3% |
| Hyperlipidaemia |
1.3% |
|
| Rash |
10.6% |
| Death |
9.7% |
| Drug Eruption |
7.8% |
| Pyrexia |
7.4% |
| Pneumonia |
6.9% |
| Toxic Skin Eruption |
6.0% |
| Interstitial Lung Disease |
5.5% |
| Urinary Retention |
5.5% |
| Intentional Drug Misuse |
4.6% |
| Rash Generalised |
4.6% |
| Somnolence |
4.1% |
| Vomiting |
4.1% |
| Liver Disorder |
3.2% |
| Off Label Use |
3.2% |
| Renal Impairment |
3.2% |
| Altered State Of Consciousness |
2.8% |
| Gastric Cancer |
2.8% |
| Loss Of Consciousness |
2.8% |
| Subarachnoid Haemorrhage |
2.8% |
| Angina Pectoris |
2.3% |
|
| Secondary |
| Rheumatoid Arthritis |
15.3% |
| Hypertension |
10.2% |
| Osteoporosis |
8.8% |
| Back Pain |
8.0% |
| Product Used For Unknown Indication |
7.2% |
| Osteoarthritis |
7.0% |
| Gastritis |
6.1% |
| Postoperative Care |
5.2% |
| Pain |
4.8% |
| Constipation |
3.5% |
| Prophylaxis |
3.4% |
| Diabetes Mellitus |
3.0% |
| Insomnia |
3.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.5% |
| Acoustic Neuroma |
2.3% |
| Asthma |
2.3% |
| Arthralgia |
2.1% |
| Hypercholesterolaemia |
2.0% |
| Analgesic Therapy |
1.6% |
| Chronic Hepatitis C |
1.5% |
|
| Drug Eruption |
13.6% |
| Stevens-johnson Syndrome |
13.6% |
| Intentional Drug Misuse |
8.8% |
| Rash |
7.2% |
| Pyrexia |
6.4% |
| Erythema |
5.6% |
| Vomiting |
5.6% |
| Toxic Skin Eruption |
4.8% |
| Rash Generalised |
4.0% |
| Cardiac Failure |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Intestinal Obstruction |
3.2% |
| Pancytopenia |
3.2% |
| Tongue Oedema |
3.2% |
| Agranulocytosis |
2.4% |
| Erythema Multiforme |
2.4% |
| Gastric Ulcer Haemorrhage |
2.4% |
| Retinal Vein Occlusion |
2.4% |
| Skin Laceration |
2.4% |
| Systemic Lupus Erythematosus |
2.4% |
|
| Concomitant |
| Rheumatoid Arthritis |
42.7% |
| Prophylaxis |
13.6% |
| Hypertension |
5.7% |
| Product Used For Unknown Indication |
4.9% |
| Osteoporosis |
4.5% |
| Pain |
3.5% |
| Cancer Pain |
3.2% |
| Chronic Hepatitis C |
2.7% |
| Insomnia |
2.7% |
| Diabetes Mellitus |
2.2% |
| Constipation |
2.1% |
| Gastritis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Multiple Myeloma |
1.4% |
| Behcet's Syndrome |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Analgesic Therapy |
1.2% |
| Hyperlipidaemia |
1.2% |
| Back Pain |
1.1% |
| Metastatic Renal Cell Carcinoma |
1.1% |
|
| Pneumonia |
9.4% |
| White Blood Cell Count Decreased |
8.8% |
| Vomiting |
8.3% |
| Breast Cancer |
5.5% |
| Hepatic Function Abnormal |
5.5% |
| Interstitial Lung Disease |
5.5% |
| Femur Fracture |
5.0% |
| Pneumocystis Jiroveci Pneumonia |
5.0% |
| Renal Impairment |
5.0% |
| Rash |
4.4% |
| Somnolence |
4.4% |
| Stomatitis |
4.4% |
| Toxic Skin Eruption |
4.4% |
| Liver Disorder |
3.9% |
| Off Label Use |
3.9% |
| Sepsis |
3.9% |
| Pyrexia |
3.3% |
| Thrombocytopenia |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Cerebral Infarction |
2.8% |
|
| Interacting |
| Back Pain |
22.2% |
| Angina Pectoris |
14.8% |
| Hyperuricaemia |
7.4% |
| Osteoporosis |
7.4% |
| Post-traumatic Pain |
7.4% |
| Prophylaxis |
7.4% |
| Constipation |
3.7% |
| Hypercholesterolaemia |
3.7% |
| Hypertension |
3.7% |
| Lipids Abnormal |
3.7% |
| Oedema Peripheral |
3.7% |
| Osteoarthritis |
3.7% |
| Pain |
3.7% |
| Pancreatitis Chronic |
3.7% |
| Pulmonary Embolism |
3.7% |
|
| Off Label Use |
50.0% |
| Prothrombin Time Prolonged |
25.0% |
| Pruritus |
25.0% |
|
